GlassScriptPhysician profile
Henry S Reed
NPI 1679612964
$472.13
in general payments reported to CMS, 2019-2025
13 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $59.15 · 2021: $35.34 · 2022: $39.95 · 2023: $28.37 · 2024: $17.74 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $113.13 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Otsuka America Pharmaceutical, INC. | $79.11 | 2019 | |
| Novo Nordisk INC | $76.66 | 2019-2023 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $38.70 | 2019-2020 | |
| Amgen INC. | $24.63 | 2022 | |
| Bard Peripheral Vascular, INC. | $23.57 | 2020 | |
| Akebia Therapeutics INC | $22.44 | 2021 | |
| Travere Therapeutics, INC. | $18.17 | 2025 | |
| Sanofi Pasteur INC. | $17.84 | 2019 | |
| Exact Sciences Corporation | $17.74 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $15.32 | 2022 | |
| Merck Sharp & Dohme LLC | $12.90 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.